The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...
The agency is proposing that device manufacturers improve their testing to including larger, more diverse sample sizes.
The FDA granted orphan drug designation to amezalpat in hepatocellular carcinoma based on phase 1b/2 data showing efficacy ...
New drug approved for treating chronic schizophrenia with fewer side effects. Could be beneficial for Black community.
But recently, the U.S. Food and Drug Administration (FDA) made changes to its criteria for which foods can be labeled as ...
A Washington state-based nonprofit has launched a program training pharmacists to prescribe abortion medications via ...
Sometimes regular English words—words that have commonsense but slightly fuzzy meanings—must be defined more precisely for ...
Green Matters on MSN51m
Does the FDA Have the Power To Move Forward With a Planned Ban on Menthol Cigarettes?The FDA has been trying to put a ban on the sale of menthol cigarettes since April 2022, but the government agency has yet to ...
During a town hall at the PA Farm Show, Agriculture Secretary Russell Redding and Penn State’s College of Agricultural Science Dean Troy Ott discussed the Shapiro Administration’s proactive strategies ...
The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...
The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...
The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback